Fribourg / Bioggio / Basel / Neuchâtel / Geneva / Berne / Zurich / Lausanne / San Diego / /
Company
Tecnopolo / Aravis Venture / GlycoVaxyn 31 Company / Biognosys / Telormedix SA / Bioengineering AG / Debiopharm Group / Novartis International AG / Proquest Venture / ETH Zurich / /
Continent
Europe / /
Country
Switzerland / /
Currency
CHF / USD / /
Event
FDA Phase / Employment Change / /
Facility
Swiss Institute of Bioinformatics / Paul Scherrer Institute / University of California San Diego / Friedrich Miescher Institute / /
IndustryTerm
integrated computational methods and tools / pharmaceutical industry / cancer therapies / high-tech industries / relevant to systems / biotechnology conferences / manufacturing process / high-tech park / interesting technologies / treatment of cancer / diagnostic tools / ome-scale metabolic networks / technology transfer / membership / important metabolic networks / job search / cellular networks / biotechnology / biological systems / shorter treatment protocol / pharmaceutical / industrial biotechnology / treatment of bladder cancer / research / biotechnology industry / large and growing network / industrial products / spin-off / /
MedicalCondition
skin cancer / microbial infections / bladder cancer / cancer / diabetes / diseases / very early-stage cancer / autoimmune diseases / insulin resistance / disease / tumour / cardiovascular disease / pain / /
MedicalTreatment
cancer therapies / treatment protocol / /
NaturalFeature
Ticino lakes / /
Organization
Swiss Institute of Bioinformatics / Swiss Life Sciences Marketing Alliance / US Federal Reserve / Friedrich Miescher Institute / Swiss National Science Foundation / Swiss Federal Government / University of California San Diego / Harvard Medical School / Swiss Biotech Association / Swiss government / SystemsX.ch / Scientific Advisory Board / Board of Directors SystemsX.ch / Paul Scherrer Institute / /
Person
Ralph Eichler / Davide Gai / Domenico Alexakis / Lorenzo Leoni / Molecular Oncology (Onc) / Roberto Maj / Stuart Holden / Alain Schreiber / Stefanie Marie Couson / Jean-Philippe Tripet / Johanna Holldack / Dennis Carson / Rolf Zinkernagel / /
Position
President / Chief Executive Officer / Paul L. Herrling Head Corporate Research / CEO / professor / Managing Director / current Head / Vice-President / pharmacist / Director in autumn / scientist / Chairman / CEO /Director / advocate the bio-based economy / current Head of Drug Development / /
Product
Venture / TMX-101 / /
Technology
proteomics / mutually interesting technologies / Human Genome / cancer detection / drug discovery / shorter treatment protocol / platform technologies / Bioinformatics / Antibodies / biotechnology / metabolic networks / Drug Development / /
90518_logo_artwork